Intensity Modulated Radiation Therapy (IMRT) promises to be superior to conventional radiation therapies for the treatment of Hodgkin's disease, according to a new study presented October 8, 2002.
Radiation after mastectomy reduces recurrence rates for breast cancer patients, according to a new study presented October 8, 2002.
Adding chemotherapy to radiation therapy and surgery failed to significantly improve control of high-risk, resected head and neck cancers, according to a new study presented October 7, 2002.
The updated results of a study confirm preliminary findings that chemotherapy can increase the chances of survival for some cervical cancer patients, according to a new study presented October 7, 2002.
Women who receive annual mammograms are more likely to have breast cancer detected when it is in its earliest, most curable stage, according to a new study presented October 7, 2002.
Undergoing chemotherapy at the same time as radiation therapy helps patients with laryngeal cancer keep their larynxes, according to a new study presented October 7, 2002.
New results from a long-term study of breast cancer patients reveal that patients who underwent lumpectomies fared just as well as patients who had mastectomies, according to a new study presented October 7, 2002.
Cervical cancer patients who were treated with radiation therapy now have a new tool for fighting sexual side effects, according to a new study presented October 7, 2002.
The location of lymph node metastases is linked to survival odds for cervical cancer patients, according to a new study presented October 7, 2002.
Adding stereotactic radiosurgery after whole brain radiation therapy improves survival for certain patients with brain metastases, according to a new study presented October 7, 2002.
The level of prostate-specific antigen (PSA) in the blood of prostate cancer patients five years after radiation treatment can help predict their disease-free survival for the next several years.
Although radiation therapy can promptly alleviate much of the pain associated with cancer, it is underutilized, according to several of the country's most distinguished cancer researchers and pain management specialists.
Radiation therapy alone is an adequate treatment for some patients with rectal cancer, according to a study.
Officials from the American Society for Therapeutic Radiology and Oncology are pleased to announce that Steven Leibel, M.D., of Memorial Sloan-Kettering Cancer Center in New York, Victor Marcial, M.D., of University of Puerto Rico School of Medicine and University Hospital in San Juan, and Marvin Rotman, M.D., of SUNY Downstate Medical Center in Brooklyn, N.Y., have been chosen to receive the Gold Medal, ASTRO's highest honor.
A new study raises questions about the quality of life benefits of radiation therapy in the treatment of testicular cancer.
Identifying the status of the p53 gene product in certain prostate cancer patients could help in determining the best treatment, according to a new study.
In light of recent news stories regarding the arrest of a man allegedly plotting a "dirty bomb" attack, the American Society for Therapeutic Radiology and Oncology would like to announce that three of its distinguished members are available to make expert comments on stories relating to this subject.
Race is not an independent predictor of whether a patient with clinically localized prostate cancer will be cured using permanent radioactive implants.
High-dose radiotherapy combined with a stem cell transplant is an effective and potentially curative therapy for select chemo-resistant lymphoma patients.
Female breast cancer patients who possess a mutation in their ATM gene may be more likely to suffer breast tissue side effects from adjuvant radiation therapy than patients who do not have such a mutation, according to a new study.
ASTRO is the largest radiation oncology society in the world, with nearly 7,000 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the society's goals are to advance the scientific base of radiation therapy and to extend the benefits of radiation therapy to those with cancer and other diseases.
Before undergoing radiation therapy for the treatment of non-small-cell lung cancer, patients should first undergo a PET scan to see if the radiation is more likely to be effective in curing the disease.
Prophylactic cranial irradiation is a cost effective way to improve the quality of life for survivors of small-cell lung cancer.
Patients who suffer from erectile dysfunction after radiation therapy for prostate cancer benefit from using Viagra, according to a new study.
Dose escalation is critical to treating patients with some types of prostate cancer, according to a new study presented November 7, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Radiation therapy is an effective way to open blocked arteries after they were previously opened by angioplasty and stents, and keep them open, providing patients an alternative to invasive surgery, according to a new study presented November 7, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Patient age and marital status are linked to quality of life, such as sexual function and spiritual well being, for long-term survivors of head and neck or prostate cancer, according to a new study presented November 6, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Patients with locally advanced head and neck cancer who receive chemotherapy and radiation therapy following surgery are more likely to survive than patients who only receive radiation therapy following surgery, according to a new study presented November 5, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Involved field radiation therapy does not improve the treatment results in patients with stage III and IV Hodgkin's Lymphoma who reach complete remission after chemotherapy. However, radiation therapy has been proven effective in treating Hodgkin's patients in partial remission, according to a new study.
Accessibility of radiation oncology physicians and treatment services are a factor as to whether breast cancer patients are able to conserve their breasts, according to a new study presented November 5, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Presence of the human papilloma virus in patients with advanced state cervical cancer may help determine the efficacy of radiation therapy in curing the cancer, according to a new study presented November 5, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
Patients treated with hormone therapy before and during whole-pelvic radiotherapy for prostate cancer are more likely to have a progression-free survival than patients receiving radiation only to the prostate or those receiving hormone therapy after radiotherapy, according to a new study presented November 5, 2001, at the American Society for Therapeutic Radiology and Oncology's Annual Meeting in San Francisco.
The type of treatment patients receive for prostate cancer can impact their quality of life, particularly during the first year after treatment, according to a new study.
Radiation treatments given before surgery for rectal cancer reduces the risk of local disease recurrence and death from the disease, according to an overview published this week.
Patients with brain metastases who receive radiotherapy -- small doses of radiation given over the course of 10 to 15 days -- and stereotactic radiosurgery -- a one-time shot of high-dose radiation -- show an extensive improvement in survival, according to a new study.
The Board of Directors for the American Society for Therapeutic Radiology and Oncology has conferred and decided to proceed with the organization's annual meeting scheduled for Nov. 4-8, 2001, at the Moscone Convention Center in San Francisco.
The American Society for Therapeutic Radiology and Oncology's annual meeting provides journalists with the opportunity to speak with the people who are making cutting-edge discoveries in their search for a cure to cancer and other diseases. Registration is free for all members of the media.
The idea that radiation therapy should only be offered to older prostate cancer patients because radiation therapy isn't a "durable treatment" has again been disproved. A new study with 10-year follow-up shows that radiation therapy does offer long-term disease- free survival.
Offering yet another reason not to smoke, a new study concludes that smoking substantially increases the risk of major gastrointestinal complications following radiation treatment for cervical cancer.
Black patients benefit as much as white patients do from post-lumpectomy radiation therapy despite a disproportionate number of factors that would seem to put them at a disadvantage.
Radiation oncologists can increase the dose of radiation and still lower the rate of complications if they use 3D-CRT when treating patients with early stage prostate cancer.
Contrary to a long-held perception, breast cancer can be just as aggressive in elderly women as it is in younger women, a new study has found.
Higher-risk prostate-cancer patients receiving radiation therapy are more likely to beat the disease when hormonal therapy is added to the treatment plan.
Researchers have found that using radiation is an effective way to open blocked arteries after they were previously opened by angioplasty and stents, and keep them open, providing patients an alternative to invasive surgery.
Women diagnosed with breast cancer on their left side needn't worry that post-lumpectomy radiation therapy will damage their heart.
In the fight against early-stage prostate cancer, radiation therapy is significantly less expensive than radical prostatectomy for primary curative treatment, researchers have found.
Breast cancer patients under the age of 50 who choose lumpectomy and radiation therapy should receive an additional boost of radiation as part of their treatment.
Patients who can obtain and maintain an erection for intercourse before treatment are much more likely to be able to do so again after treatment if they have radiation therapy compared to radical prostatectomy.
Long-term hormone treatment plus radiation in locally advanced prostate cancer can prevent recurrence and improve survival, a new study shows. The study by the Radiation Therapy Oncology Group was the largest phase III prostate radiation treatment trial to date.
Patients with locally advanced non-small cell lung cancer live longer if they are treated with radiation therapy and chemotherapy at the same time rather than by chemotherapy first followed by radiation therapy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right